These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 18721174)

  • 1. Reported lifetime aberrant drug-taking behaviors are predictive of current substance use and mental health problems in primary care patients.
    Fleming MF; Davis J; Passik SD
    Pain Med; 2008 Nov; 9(8):1098-106. PubMed ID: 18721174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association between benzodiazepine prescription and aberrant drug-related behaviors in primary care patients receiving opioids for chronic pain.
    Park TW; Saitz R; Nelson KP; Xuan Z; Liebschutz JM; Lasser KE
    Subst Abus; 2016; 37(4):516-520. PubMed ID: 27092738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does report of craving opioid medication predict aberrant drug behavior among chronic pain patients?
    Wasan AD; Butler SF; Budman SH; Fernandez K; Weiss RD; Greenfield SF; Jamison RN
    Clin J Pain; 2009; 25(3):193-8. PubMed ID: 19333168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescription opioid aberrant behaviors: a pilot study of sex differences.
    Back SE; Payne RA; Waldrop AE; Smith A; Reeves S; Brady KT
    Clin J Pain; 2009; 25(6):477-84. PubMed ID: 19542794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant behaviors with prescription opioids and problem drug use history in a community-based cohort of HIV-infected individuals.
    Hansen L; Penko J; Guzman D; Bangsberg DR; Miaskowski C; Kushel MB
    J Pain Symptom Manage; 2011 Dec; 42(6):893-902. PubMed ID: 21802896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substance use disorders in a primary care sample receiving daily opioid therapy.
    Fleming MF; Balousek SL; Klessig CL; Mundt MP; Brown DD
    J Pain; 2007 Jul; 8(7):573-82. PubMed ID: 17499555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prescription opioid abuse and misuse: gap between primary-care investigator assessment and actual extent of these behaviors among patients with chronic pain.
    Setnik B; Roland CL; Pixton GC; Sommerville KW
    Postgrad Med; 2017 Jan; 129(1):5-11. PubMed ID: 27782769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting aberrant drug behavior in patients treated for chronic pain: importance of abuse history.
    Michna E; Ross EL; Hynes WL; Nedeljkovic SS; Soumekh S; Janfaza D; Palombi D; Jamison RN
    J Pain Symptom Manage; 2004 Sep; 28(3):250-8. PubMed ID: 15336337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying prescription opioid use disorder in primary care: diagnostic characteristics of the Current Opioid Misuse Measure (COMM).
    Meltzer EC; Rybin D; Saitz R; Samet JH; Schwartz SL; Butler SF; Liebschutz JM
    Pain; 2011 Feb; 152(2):397-402. PubMed ID: 21177035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors? A structured evidence-based review.
    Fishbain DA; Cole B; Lewis J; Rosomoff HL; Rosomoff RS
    Pain Med; 2008; 9(4):444-59. PubMed ID: 18489635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measuring opioid dependence in chronic pain patients: A comparison between addiction clinic and pain clinic patient populations.
    McDonough M; Johnson JL; White JM; Buisman-Pijlman FTA
    J Opioid Manag; 2019; 15(4):285-293. PubMed ID: 31637681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of opioid medications for chronic noncancer pain syndromes in primary care.
    Reid MC; Engles-Horton LL; Weber MB; Kerns RD; Rogers EL; O'Connor PG
    J Gen Intern Med; 2002 Mar; 17(3):173-9. PubMed ID: 11929502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic opioid therapy urine drug testing in primary care: prevalence and predictors of aberrant results.
    Turner JA; Saunders K; Shortreed SM; LeResche L; Riddell K; Rapp SE; Von Korff M
    J Gen Intern Med; 2014 Dec; 29(12):1663-71. PubMed ID: 25217208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant drug-related behavior observed during clinical studies involving patients taking chronic opioid therapy for persistent pain and fentanyl buccal tablet for breakthrough pain.
    Passik SD; Messina J; Golsorkhi A; Xie F
    J Pain Symptom Manage; 2011 Jan; 41(1):116-25. PubMed ID: 20580202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term opioid therapy, aberrant behaviors, and substance misuse: comparison of patients treated by resident and attending physicians in a general medical clinic.
    Colburn JL; Jasinski DR; Rastegar DA
    J Opioid Manag; 2012; 8(3):153-60. PubMed ID: 22798175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining problematic pharmaceutical opioid use among people prescribed opioids for chronic noncancer pain: do different measures identify the same patients?
    Campbell G; Bruno R; Lintzeris N; Cohen M; Nielsen S; Hall W; Larance B; Mattick RP; Blyth F; Farrell M; Degenhardt L
    Pain; 2016 Jul; 157(7):1489-1498. PubMed ID: 26963848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low Risk of Producing an Opioid Use Disorder in Primary Care by Prescribing Opioids to Prescreened Patients with Chronic Noncancer Pain.
    Cheatle MD; Gallagher RM; O'Brien CP
    Pain Med; 2018 Apr; 19(4):764-773. PubMed ID: 28379504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substance misuse treatment for high-risk chronic pain patients on opioid therapy: a randomized trial.
    Jamison RN; Ross EL; Michna E; Chen LQ; Holcomb C; Wasan AD
    Pain; 2010 Sep; 150(3):390-400. PubMed ID: 20334973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of opioid problems among chronic pain patients in a general medical population.
    Banta-Green CJ; Merrill JO; Doyle SR; Boudreau DM; Calsyn DA
    Drug Alcohol Depend; 2009 Sep; 104(1-2):43-9. PubMed ID: 19473787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioids for chronic noncancer pain: prediction and identification of aberrant drug-related behaviors: a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline.
    Chou R; Fanciullo GJ; Fine PG; Miaskowski C; Passik SD; Portenoy RK
    J Pain; 2009 Feb; 10(2):131-46. PubMed ID: 19187890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.